Cholecystectomy Except by Laparoscope DRG 416

DRG 416 applies to open cholecystectomy cases without common duct exploration and without Major Complication or Comorbidity or Complication or Comorbidity, defining the inpatient clinical scope for payment. Correct classification influences Medicare inpatient reimbursement by setting the bundled payment level tied to procedure complexity and documented complications.

DRG 416 Overview

DRG 416 covers inpatient admissions for cholecystectomy procedures performed without laparoscopic technique, without common duct exploration, and without Major Complication or Comorbidity or Complication or Comorbidity. This Diagnosis-Related Group reflects a relatively straightforward open cholecystectomy clinical course. It matters for Medicare payment because the grouping determines the bundled payment amount for the entire hospitalization under the inpatient prospective payment system. Accurate coding and documentation of procedure type and presence or absence of Major Complication or Comorbidity or Complication or Comorbidity directly affect DRG assignment and reimbursement.

Perioperative risk stratification and optimization studies: prospective cohort or interventional trials that evaluate protocols for preoperative assessment, timing of surgery, and perioperative optimization (for example, fluid management, antibiotic prophylaxis timing, and comorbidity stabilization) in adults undergoing open cholecystectomy without common duct exploration and without major complications. These studies focus on patients with symptomatic gallbladder disease who are not candidates for laparoscopic approach or present with anatomy/conditions requiring open surgery, and they measure short-term surgical morbidity, length of stay, and readmission. Results are relevant to surgeons, hospitalists, and payers because improved risk stratification and standardized perioperative pathways can reduce complications, resource utilization, and unplanned extended inpatient stays.
Comparative effectiveness trials of surgical approach and perioperative care bundles: randomized or pragmatic trials comparing open cholecystectomy techniques, anesthesia modalities (general vs combined regional/GA), or care bundles (enhanced recovery versus usual care) in adults without common duct exploration and without CC/MCC. These trials enroll typical inpatient surgical candidates for non-laparoscopic cholecystectomy and evaluate outcomes such as postoperative pain control, time to oral intake, length of stay, complication rates, and cost-effectiveness. Findings inform clinical decision-making and reimbursement policies by identifying approaches that maintain safety while shortening hospitalization and lowering direct inpatient costs.
Post-discharge outcomes and utilization research: observational studies and registry-based analyses that follow patients after discharge to assess readmissions, wound complications, functional recovery, return-to-work, and downstream healthcare utilization in patients who had open cholecystectomy without C.D.E. and without major complications. These studies often stratify by baseline frailty, comorbidity burden, and social determinants to identify predictors of prolonged recovery or readmission, and they test transitional care interventions such as targeted discharge planning or telephonic follow-up. Evidence from these studies helps providers and payers design post-acute care pathways, bundle payments, and targeted interventions to reduce readmissions and total episode spending while maintaining quality of care.

Perioperative risk stratification and optimization studies: prospective cohort or interventional trials that evaluate protocols for preoperative assessment, timing of surgery, and perioperative optimization (for example, fluid management, antibiotic prophylaxis timing, and comorbidity stabilization) in adults undergoing open cholecystectomy without common duct exploration and without major complications. These studies focus on patients with symptomatic gallbladder disease who are not candidates for laparoscopic approach or present with anatomy/conditions requiring open surgery, and they measure short-term surgical morbidity, length of stay, and readmission. Results are relevant to surgeons, hospitalists, and payers because improved risk stratification and standardized perioperative pathways can reduce complications, resource utilization, and unplanned extended inpatient stays.
Comparative effectiveness trials of surgical approach and perioperative care bundles: randomized or pragmatic trials comparing open cholecystectomy techniques, anesthesia modalities (general vs combined regional/GA), or care bundles (enhanced recovery versus usual care) in adults without common duct exploration and without CC/MCC. These trials enroll typical inpatient surgical candidates for non-laparoscopic cholecystectomy and evaluate outcomes such as postoperative pain control, time to oral intake, length of stay, complication rates, and cost-effectiveness. Findings inform clinical decision-making and reimbursement policies by identifying approaches that maintain safety while shortening hospitalization and lowering direct inpatient costs.
Post-discharge outcomes and utilization research: observational studies and registry-based analyses that follow patients after discharge to assess readmissions, wound complications, functional recovery, return-to-work, and downstream healthcare utilization in patients who had open cholecystectomy without C.D.E. and without major complications. These studies often stratify by baseline frailty, comorbidity burden, and social determinants to identify predictors of prolonged recovery or readmission, and they test transitional care interventions such as targeted discharge planning or telephonic follow-up. Evidence from these studies helps providers and payers design post-acute care pathways, bundle payments, and targeted interventions to reduce readmissions and total episode spending while maintaining quality of care.

OpenPayer

Summary & Overview

Cholecystectomy Except by Laparoscope without C.D.E. without CC/MCC: Inpatient Reimbursement Overview

DRG 416 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes